Logo1
PSHP - PSHP Annual Assembly 2014
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
PHARMACISTS AND PHARMACY TECHNICIANS ONLY -- Please provide the following:
NABP eProfile ID (ePID):
Date of Birth (MM/DD) - Example September 24 would be 0924:
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the following:
The program was relevant to my work.
Content matched stated objectives.
Usefulness of handouts/AV.
Quality of facilities.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situtation):
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
Objective 2: List the pharmacists and technicians updates in the law as it relates to pharmacy practice
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Objective 3: Summarize the pharmacists and technicians updates to general practice
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Discuss the current topics pertaining to PSHP
Identify and discuss the current healthcare environment and its effects on services that pharmacists provide
Discuss the current topics pertaining to PSHP
Discuss the impact that the current healthcare environment has on the duties and responsibilities of pharmacy technicians
Name the important roles for Pharmacists within Specialty Pharmacy
Name the unique roles for Pharmacy Technicians within Specialty Pharmacy
Review the major pathophysiologic defects in Type 2 Diabetes and targeted sites for medications
Describe the newer antidiabetic medication classes along with specific agents within the classes
Name new agents in the course of carrying out their duties
Discuss Pharmacy Report to the U.S. Surgeon General
Express transformative thinking based on current health system needs and pharmacy practice
Explain the importance of facilitating partnerships at the state level to help transform the profession
Explain a call-to-action that will improve the Nation's health
Discuss how pharmacy may change based on the recommendations of the U.S. Surgeon General
List ways of advocating for change at the state level
State one recommendation of the Surgeon General to address the health of the Nation
Define practice model and how the Pharmacy Practice Model Initiative (PPMI) can help advance practice models in hospitals
Identify key drivers of pharmacy practice change over the past 50 years
Explain how the elevating the training and credentialing of pharmacists is key to future practice models
Describe the changes in adoption of automation and technology and how it creates new opportunities for pharmacy
Describe a how you can use the information presented to evaluate and advance practice of pharmacists and technicians in your setting practice setting
Describe the evolution of dispensing models over the past fifty years, and what model is likely to exist in the future in hospitals
Explain how GPOs and prime vendors have evolved over time and the impact on pharmacy staff time spent on inventory control
Explain how the availability of qualified pharmacy technicians will play a pivotal role in enabling the advancing pharmacy practice and improving quality of care
List three new, non-traditional roles for pharmacy technicians and how they fit into the goals of the PPMI and future practice.
Describe why standardized technician training, certification and licensure are critical to future pharmacy practice models
Demonstrate an understanding of updated regulations regarding compounding pharmacies
Explain the considerations that should be evaluated when deciding to outsource compounded products
Recall the regulatory requirements necessary when outsourcing compounded sterile products
Describe the quality assurance requirements of an outsourced compounding pharmacy
List PSHP Advocacy Activities that have occurred
Describe your role in Advocacy or the legislative process
Name the importance of advocacy to the pharmacy community and public
Describe the technician bills in Pennsylvania
Describe how a bill becomes law
Explain how to speak to your representative or Senator
Review measures for success and data collection for safety initiatives
Identify barriers for implementation of safety initiatives
Describe elements involved in pharmacogenetic influences on pharmacodynamics
List examples of dietary supplement quality issues that have been reported by the FDA in the past year
Discuss the various processes that can be used to evaluate the quality of dietary supplements
Discuss medication safety initiatives incorporated into practice at my institution
Show various parameters that are under consideration when making dosing decisions for pediatric patients of different ages
Identify if a dietary supplement may pose a quality concern for a patient's use
Explain the various tools that can be used to evaluate the quality of dietary supplements
Describe appropriate preparation, dispensing and storage of epoprostenol
Review the scope of opioid related harm in hospitalized patients
Review regulatory recommendations and requirements for the appropriate use and monitoring of opioids in a hospitalized patient
Review types of diversion and methods to identify
Review some common look-alike sound-alike high risk errors that can occur in hospitalized patients
Review potency differences of various high-risk opioids
Describe the role of pharmacists in accountable care organizations (ACO)
List four key areas to address when developing an ambulatory care practice
Describe activities of a care transition pharmacist
List 3 resources to assist with planning pharmacy services in an ACO
Describe the 3 key elements of an accountable care organization
Describe activities of a pharmacy technician to support care transitions
List 3 examples of pharmacy technician role in an ACO
Summarize the results of clinical trials for the newest medications approved for hepatitis C treatment and where these medications fit into treatment decisions
Discuss how to develop a clinical pharmacist program for the treatment of hepatitis C and become an integral part of the treatment team
Apply knowledge of the medication options for hepatitis C to patient cases
Summarize the major side effects for the newest medications approved for hepatitis C treatment and why patients may benefit more from these medications
Discuss how a technician may help in the treatment of patients with hepatitis C
Apply knowledge of the medication options for hepatitis C to patient cases
Discuss how interprofessional education (IPE) learning experiences prepare graduates to develop meaningful partnerships and add value to your institution
Describe opportunities for student and resident involvement in an interprofessional group medical visit practice model
Describe resident and student involvement in the medication reconciliation and discharge processes at an urban, teaching medical center
Identify opportunities for student and resident research involvement associated with the medication reconciliation and discharge processes
Identify three opportunities to integrate student pharmacists and residents into a transitions of care (TOC) model that incorporates a community hospital and pharmacy
Discuss how interprofessional education (IPE) learning experiences between pharmacy and technician students is a meaningful way for both to learn
Describe opportunities for students of pharmacy and technician programs to train together at a clinical site
Describe technician student involvement in the medication reconciliation and discharge processes at an urban, teaching medical center
Explain a call-to-action that will improve the Nation's health
Objective 4: Name the pharmacists and technicians updates in the area of patient safety
By meeting the above objective my professional competence will increase because I have acquired new strategies to use in my practice.
By meeting the above objective my professional performance will improve because I should be able to implement the new strategies.
By meeting the above objective my patient outcomes should improve due to the implementation of newly-learned strategies.
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?
If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?
Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
How much did you learn as a result of this education program?
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (the overall meeting) be improved to better impact competence, performance and/or patient/client outcomes?

Additional comments:

Mr question